(Q83061885)

English

Prospective randomized trial of natural interferon-alpha versus natural interferon-alpha plus cimetidine in advanced renal cell carcinoma with pulmonary metastasis

scientific article published on 04 April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Prospective randomized trial of natural interferon-alpha versus natural interferon-alpha plus cimetidine in advanced renal cell carcinoma with pulmonary metastasis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

renal cell carcinoma

1 reference

based on heuristic

inferred from title

Taiji Tsukamoto

3

object named as

Taiji Tsukamoto

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Toshiaki Kinouchi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Junichi Sakamoto

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Hideyuki Akaza

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Yoshinobu Kubota

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Seiichiro Ozono

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Hiroshi Kanetake

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Tetsuo Taguchi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Toshihiko Kotake

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Immunotherapy Oncology Group for Renal Cell Carcinoma

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

4 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

132

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

499-504

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

https://scigraph.springernature.com/pub.10.1007/s00432-006-0095-7

0 references

Cimetidine: an immunomodulator

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic malignant melanoma: regression induced by combined treatment with interferon [HuIFN-alpha(Le)] and cimetidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose cimetidine for the treatment of metastatic renal cell carcinoma. A Hoosier Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy for metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An assessment of the current use of human interferons in therapy of urological cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evaluation of recombinant leukocyte A interferon with aspirin in patients with metastatic renal cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-course cimetidine and survival with colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cimetidine and survival with colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A cooperative phase I-II study of HLBI in patients with malignant tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[A study of the clinical response of renal cell carcinoma to human lymphoblastoid interferon (MOR-22)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised study using IFN-alpha versus IFN-alpha plus coumarin and cimetidine for treatment of advanced renal cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology

1 reference

https://pubmed.ncbi.nlm.nih.gov/16586071

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-006-0095-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16586071%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83061885&oldid=1829474428"